10 Years of Molecular Autism
2020 marked a decade since Molecular Autism was established to accelerate and integrate research into neurodevelopmental conditions.
Read our retrospective collection of the most impactful publications from the last ten years here.
Announcing the launch of In Review
Atypical functional connectivity of temporal cortex with precuneus and visual regions may be an early-age signature of ASD
Sex differences in social and emotional insight in youth with and without autism
Sex differences in friendships and loneliness in autistic and non-autistic children across development
Impaired neurogenesis and neural progenitor fate choice in a human stem cell model of SETBP1 disorder
Hans Asperger, National Socialism, and “race hygiene” in Nazi-era Vienna
Savant syndrome has a distinct psychological profile in autism
Quantifying compensatory strategies in adults with and without diagnosed autism
Environmental risk factors for autism: an evidence-based review of systematic reviews and meta-analyses
Sex differences in the first impressions made by girls and boys with autism
Simon Baron-Cohen, University of Cambridge, UK
Joseph Buxbaum, Icahn School of Medicine at Mount Sinai, New York
Aims and scope
Molecular Autism is a peer-reviewed, open access journal that publishes high-quality basic, translational and clinical research that has relevance to the etiology, pathobiology, or treatment of autism and related neurodevelopmental conditions. Research that includes integration across levels is encouraged. Molecular Autism publishes empirical studies, reviews, and brief communications.
We encourage submissions from a range of fields including (but not restricted to) genetics, molecular neurobiology, neuropathology, neuroimaging, cognitive neuroscience, epidemiology, and biomarker discovery. Molecular Autism also publishes articles on screening, diagnosis and classification, including articles that consider subgrouping to refine our understanding of basic mechanisms. Intervention studies are also welcome, especially when considered with respect to revealing causal mechanisms.
Joseph Buxbaum, co-Editor-in-Chief
Joseph Buxbaum is a molecular geneticist and neuroscientist, Director of the Seaver Autism Center for Research and Treatment, and Professor at the Icahn School of Medicine at Mount Sinai. Dr Buxbaum is the founder and co-lead investigator of the Autism Sequencing Consortium, an international collaboration to discover genes for autism. He has also been elected to the prestigious National Academy of Medicine (NAM), in recognition of his important contributions to uncovering the genetic and molecular basis of autism.
Simon Baron-Cohen, co-Editor-in-Chief
Simon Baron-Cohen is Professor of Developmental Psychopathology at the University of Cambridge and Fellow at Trinity College, Cambridge. He is also Director of the Autism Research Centre (ARC) in Cambridge and Director of CLASS (Cambridge Lifespan Asperger Syndrome Service), a clinic for adults with suspected AS.
Annual Journal Metrics
6.503 - 2-year Impact Factor (2021)
8.013 - 5-year Impact Factor (2021)
1.882 - Source Normalized Impact per Paper (SNIP)
1.666 - SCImago Journal Rank (SJR)
29 days to first decision for all manuscripts (Median)
53 days to first decision for reviewed manuscripts only (Median)
902,898 downloads (2021)
2,760 Altmetric mentions (2021)